Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1028327-66-3

Post Buying Request

1028327-66-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1028327-66-3 Usage

Uses

VUF 10460 is a histamine H4 receptor antagonist.

Check Digit Verification of cas no

The CAS Registry Mumber 1028327-66-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,8,3,2 and 7 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1028327-66:
(9*1)+(8*0)+(7*2)+(6*8)+(5*3)+(4*2)+(3*7)+(2*6)+(1*6)=133
133 % 10 = 3
So 1028327-66-3 is a valid CAS Registry Number.

1028327-66-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name VUF 10460

1.2 Other means of identification

Product number -
Other names 4-(4-Methyl-piperazin-1-yl)-6-phenyl-pyrimidin-2-ylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1028327-66-3 SDS

1028327-66-3Downstream Products

1028327-66-3Relevant articles and documents

Mapping histamine H4 receptor-ligand binding modes

Schultes, Sabine,Nijmeijer, Saskia,Engelhardt, Harald,Kooistra, Albert J.,Vischer, Henry F.,De Esch, Iwan J. P.,Haaksma, Eric E. J.,Leurs, Rob,De Graaf, Chris

, p. 193 - 204 (2013/03/13)

The increasing number of G protein-coupled receptor (GPCR) crystal structures offers new opportunities for histamine receptor homology modeling. However, computational prediction of ligand binding modes in GPCRs such as the histamine H4 receptor (H4R), a receptor that plays an important role in inflammation, remains a challenging task. In the current work we have combined complementary in silico receptor modeling approaches with in vitro ligand structure-activity relationship (SAR) and protein site-directed mutagenesis studies to elucidate the binding modes of different ligand classes in H4R. By systematically considering different H4R modelling templates, ligand binding poses, and ligand protonation states in combination with docking and MD simulations we are able to explain ligand-specific mutation effects and subtle differences in ligand SAR. Our studies confirm that a combined theoretical and experimental approach represents a powerful strategy to map ligand-protein interactions. The Royal Society of Chemistry 2013.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1028327-66-3